Table 5.
Median (IQR) No. | Summary | |
---|---|---|
Sick leave in vaccinees without a history of SARS-CoV-2 infection | ||
Potential sick leave in daysa | ||
After first vaccination | 2 (1–3) n = 239 | 639 |
After second vaccination | 2 (1–3) n = 538c | 1292 |
Actual sick leave in daysb | ||
After first vaccination | 1 (0–2) n = 239 | 333 |
After second vaccination | 1 (0–2) n = 538c | 770 |
Sick leave in vaccinees with a history of SARS-CoV-2 infectiond | ||
Potential sick leave in daysa | ||
After first vaccination | 2 (2–4) n = 41 | 138 |
After second vaccination | 2 (1.5–4) n = 24 | 65 |
Actual sick leave in daysb | ||
After first vaccination | 1 (1–2) n = 41 | 82 |
After second vaccination | 1 (0–2) n = 24 | 31 |
Sick leave because of SARS-CoV-2 infection | 14 (10–21)c n = 250 | 4642 |
Sick leave because of SARS-CoV-2 quarantine | 14 (10–14)c n = 352 | 4710 |
Abbreviations: COVID-19, coronavirus disease 2019; IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Survey participants were asked how many days they would have been unable to go to work because of COVID-19 vaccination–associated adverse reactions if the vaccination day was followed by days off (weekend, holidays, etc.).
Survey participants were asked how many days they actually were on sick leave.
One implausible value recoded to missing.
SARS-CoV-2 infection may have occurred before, during, or after the vaccination process.